• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD ACCESS SYSTEMS POWERPICC SOLO CATHETER WITH SHERLOCK 3CG TPS STYLET 4F MAXIMAL BARRIER TRAY; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD ACCESS SYSTEMS POWERPICC SOLO CATHETER WITH SHERLOCK 3CG TPS STYLET 4F MAXIMAL BARRIER TRAY; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS Back to Search Results
Model Number 1194108D
Device Problem Malposition of Device (2616)
Patient Problems Pain (1994); Loss of Vision (2139)
Event Type  Injury  
Manufacturer Narrative
The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.The following were reviewed as part of this investigation: patient severity, frequency analysis, applicable previous investigation(s), sample (if available), applicable fmea documents, labeling, and applicable manufacture records.Based on a review of this information, the following was concluded: the complaint of an arterial placement could not be verified with the evidence provided for investigation.One photo of an ecg printout was provided for investigation.The printout showed both the external and intravascular waveforms.That the picc tip was residing in the thoracic aorta was inconclusive.No further action is required because the reported event could not be related to a deficiency in product manufacture or deficiency while under correct product use.The product ifu states, ¿the powerpicc solo2 ® catheter is indicated for short or long term peripheral access to the central venous system for intravenous therapy, power injection of contrast media, and allows for central venous pressure monitoring.¿ one of the placement warnings in the ifu states, ¿if the artery is entered, withdraw the needle and apply manual pressure for several minutes.¿ during venipuncture, the ifu warns, ¿if the artery is entered, withdraw the needle or safety iv catheter and apply manual pressure for several minutes.¿ the picc placement ifu with sherlock 3cg stylet provides the following instructions.¿the sherlock 3cg* tps stylet, sherlock 3cg* tcs system, and the site~rite* ultrasound system, include a comprehensive, integrated set of picc placement tools such as vein location, lumen size visualization, needle guided vein access, catheter tip orientation, catheter tip depth, catheter tip placement using ecg, and ecg placement documentation.¿ ¿select a vein based on patient assessment and pre-scan.Recommended veins are basilic, cephalic, and brachial veins.¿ ¿7.Access vein a.Perform ultrasound and locate vessel.Follow ultrasound system instructions for use.Perform microintroduction.Follow catheter instructions for use regarding microintroduction technique.Secure guidewire.¿ a lot history review (lhr) of recq1422 showed no other similar product complaint(s) from this lot number.
 
Event Description
It was reported picc was placed in a brachial vein using sherlock 3cg to confirm placement.Soon after insertion, the patient lost vision.The patient developed pain in her arm and became agitated.Cxr, doppler and blood gasses were done and showed picc was arterial with the tip residing in the thoracic aorta.These weren¿t done until (b)(6) when the picc was then removed.On (b)(6) 2018-facility reported that patient was septic unknown if vision loss was related to picc placement or antibiotic administration.Picc removed patient discharged.Vision is improving.Reviewed clinical signs or arterial placement with picc leader.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPICC SOLO CATHETER WITH SHERLOCK 3CG TPS STYLET 4F MAXIMAL BARRIER TRAY
Type of Device
CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS
Manufacturer (Section D)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas
MX  
Manufacturer Contact
shelly gilbert
605 n. 5600 w.
salt lake city, UT 84116
8015225640
MDR Report Key7614450
MDR Text Key111525879
Report Number3006260740-2018-01432
Device Sequence Number1
Product Code LJS
UDI-Device Identifier00801741034510
UDI-Public(01)00801741034510
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K091324
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Reporter Occupation Health Professional
Type of Report Initial
Report Date 06/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number1194108D
Device Catalogue Number1194108D
Device Lot NumberRECQ1422
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/29/2018
Is the Reporter a Health Professional? Yes
Event Location Hospital
Initial Date Manufacturer Received 05/29/2018
Initial Date FDA Received06/19/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/01/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age71 YR
-
-